Skip to content

A Trial Whose Time Has Come

Yesterday, we hosted our first, and certainly not last, investor day. We had three doctors on stage (two of which were CEOs of our favorite positions), we talked about the Builders (with more to come on that), and launched a…

Read more
Back To Top